Spectaire (NASDAQ:SPEC) vs. Callitas Health (OTCMKTS:MPHMF) Critical Comparison

Spectaire (NASDAQ:SPEC) and Callitas Health (OTCMKTS:MPHMF) are both computer and technology companies, but which is the better investment? We will compare the two businesses based on the strength of their profitability, analyst recommendations, valuation, institutional ownership, risk, earnings and dividends.

Volatility & Risk

Spectaire has a beta of -0.46, suggesting that its share price is 146% less volatile than the S&P 500. Comparatively, Callitas Health has a beta of -3.5, suggesting that its share price is 450% less volatile than the S&P 500.

Valuation & Earnings

This table compares Spectaire and Callitas Health”s revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Spectaire	N/A	N/A	$8.95 million	N/A	N/A
Callitas Health	$530,000.00	N/A	-$1.28 million	N/A	N/A

Spectaire has higher earnings, but lower revenue than Callitas Health.

Profitability

This table compares Spectaire and Callitas Health’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Spectaire	N/A	-81.22%	304.57%
Callitas Health	N/A	N/A	N/A

Institutional & Insider Ownership

26.6% of Spectaire shares are held by institutional investors. 25.4% of Spectaire shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Analyst Recommendations

This is a summary of recent ratings and recommmendations for Spectaire and Callitas Health, as provided by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Spectaire	0	1	0	0	2.00
Callitas Health	0	0	0	0	0.00

Spectaire presently has a consensus target price of $2.50, suggesting a potential upside of 4,900.00%. Given Spectaire’s stronger consensus rating and higher probable upside, analysts clearly believe Spectaire is more favorable than Callitas Health.

Summary

Spectaire beats Callitas Health on 7 of the 9 factors compared between the two stocks.

About Spectaire

Spectaire Holdings Inc. provides solutions that measure, manage, and reduce carbon dioxide equivalent and other greenhouse gas emissions. The company offers AireCore, an integrated hardware, software, and data platform for logistics and supply chain players that uses mass spectrometry to directly measure their emissions. It serves the logistics, energy, agriculture, academics, and indoor air industries. The company is based in Watertown, Massachusetts.

About Callitas Health

Callitas Health, Inc. is a clinical stage company. It engages in the development of technologies for obesity, weight management, and female health and wellness. The company focuses on developing technologies for weight management, female sexual health and wellness, cannabis delivery technologies and other proprietary drugs. It launched product ToConceive in North America. The firm researches, develops and business development processes for its other OTC products, CannaMint strips and orphan drug technologies. Callitas Health was founded on March 11, 2003 and is headquartered in Newport, KY.